Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Get the latest international news and world events from around the world.

Log in for authorized contributors

Christian Maugee — PhD Candidate, University Of Florida — From Patient To Genetics Research Pioneer

From patient to genetics research pioneer — christian maugee — phd candidate, university of florida.

Christian Maugee is a PhD Candidate at the University of Florida, in Genetics and Genomics (http://www.vulpelab.net/graduate-and-undergrad-students.html where his research explores how gene expression differs in the hearts of individuals with Friedrich’s Ataxia (FA), a rare, progressive neurodegenerative disease. His work could lead to new insights into the cardiac complications that can be associated with FA and how to potential treat them better.

Christian’s dissertation work is focused on identifying gene modulators of the transcriptional phenotype of FA in human induced pluripotent stem cells differentiated into cardiomyocytes (hPSC-CMs). He accomplishes this through use of a novel method: Perturb-seq — a CRISPR screen coupled with single cell RNA sequencing (scRNA-seq) readout.

Christian is driven by much more than academic curiosity, as he brings a unique and deeply human perspective to his work as someone living with FA. He doesn’t just study the challenges faced by those with disabilities; he lives them. His work is not only informed by data and theory, but by resilience, authenticity, and a commitment to making research more inclusive and impactful.

In the lab, Christian loves mentoring, and outside of the lab he loves fundraising and raising awareness for FA, mainly through FARA (https://www.curefa.org/) and MDA (https://www.mda.org/disease/friedreic…).

Continue reading “Christian Maugee — PhD Candidate, University Of Florida — From Patient To Genetics Research Pioneer” | >

A hidden “backup heater” that helps burn fat and boost metabolism

Scientists at Washington University School of Medicine in St. Louis have uncovered a new way that brown fat, a type of fat that burns energy, can boost the body’s metabolism. This process allows cells to consume more fuel and generate heat, improving overall metabolic health. Conducted in mice, the research points to new possibilities for using brown fat to address metabolic conditions such as insulin resistance and obesity.

The findings were published Sept. 17 in Nature.

Brown fat is unique because it turns energy (calories) from food into heat. Unlike white fat, which stores energy, or muscle, which uses it immediately, brown fat helps keep the body warm in cold environments. Exposure to cold can increase the amount of brown fat, and scientists have long suggested that activating it could support weight loss by increasing calorie burning.

Biohybrid leaf mimics photosynthesis to turn CO₂ and sunlight into useful chemicals

Researchers have demonstrated a new and sustainable way to make the chemicals that are the basis of thousands of products—from plastics to cosmetics—we use every day.

Hundreds of thousands of chemicals are manufactured by the chemical industry, which transforms raw materials—usually fossil fuels—into useful end products. Due to its size and its use of fossil fuel feedstocks, the chemical industry is responsible for roughly 6% of global carbon emissions.

But researchers led by the University of Cambridge are developing new methods that could one day lead to the “de-fossilization” of this important sector.

Targeting enzymes to weaken cancer cells could supercharge prostate cancer treatment

An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one of the most common cancers affecting men.

The research, published in the journal Proceedings of the National Academy of Sciences, was led by scientists from Flinders University in Australia and South China University of Technology.

It reveals that two enzymes—PDIA1 and PDIA5—play a crucial role in helping prostate cancer cells grow, survive, and resist treatment.

Retinal implant restores central vision in patients with advanced AMD, study shows

A wireless retinal implant can restore central vision in patients with advanced age-related macular degeneration (AMD), according to clinical trial results published in the New England Journal of Medicine.

Advanced atrophic AMD, also known as geographic atrophy (GA), is the leading cause of irreversible blindness in , affecting more than 5 million people worldwide.

The international, multi-center trial was co-led by José-Alain Sahel, M.D., director of the UPMC Vision Institute, Daniel Palanker, Ph.D., professor of ophthalmology at Stanford University, and Frank Holz, M.D., professor of ophthalmology at the University of Bonn, Germany.

/* */